Juan Ravell, MD
Allergy & Immunology · Hackensack, NJNPI 1629301817
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.6% of the total across 119 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 12.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $518, 9.9 times the $52 reported in 2020. That places this record below the midpoint for allergy & immunology clinicians in NJ, where the typical reported total is $3,288.
Across 119 payments — averaging $16.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$238
- Amgen$200
- Biocryst US Sales Co., LLC$191
- Pfizer$172
- Regeneron Healthcare Solutions, Inc.$170
- AbbVie$142
- plus $834 from 20 others
Across 1 payment — averaging $77,828 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$78K
What the payments were for
- Consulting fees$362%
- Food & beverage$1,84395%
- Education$694%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 16 | $238 |
| Amgen(2 entities) | 11 | $200 |
| Biocryst US Sales Co., LLC | 12 | $191 |
| Pfizer | 10 | $172 |
| Regeneron Healthcare Solutions, Inc. | 10 | $170 |
| AbbVie | 10 | $142 |
| Optinose US, Inc. | 7 | $111 |
| LEO Pharma Inc. | 7 | $106 |
| Pharming Healthcare, Inc. | 5 | $78 |
| CSL Behring | 3 | $54 |
| Grifols USA, LLC | 3 | $51 |
| Organon | 3 | $49 |
| Bio Products Laboratory USA, Inc. | 2 | $41 |
| Genentech USA, Inc. | 2 | $38 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $37 |
| Teva Pharmaceuticals USA, Inc. | 3 | $36 |
| GC Biopharma USA, Inc. | 2 | $36 |
| ADMA Biomanufacturing LLC | 2 | $36 |
| Tersera Therapeutics LLC | 1 | $33 |
| Aimmune Therapeutics, Inc. | 2 | $30 |
| Octapharma USA, Inc. | 1 | $30 |
| Blueprint Medicines Corporation | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| AstraZeneca | 1 | $13 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
| Kaleo, Inc. | 1 | $12 |
How this compares
$1,948 in reported general payments places this provider in the 35th percentile of 135 allergy & immunology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GammakedImmune Globul G/Gly/Iga Avg 46 | 29 | $136,208 |
| HizentraImmun Glob G(Igg)/Pro/Iga 0-50 | 12 | $121,556 |
| GammaplexImmun Glob G(Igg)/Gly/Iga 0-50 | 12 | $86,936 |
| XolairOmalizumab | 12 | $34,498 |
| Epinephrine | 23 | $4,670 |
| Fluticasone Propionate HfaFluticasone Propionate | 14 | $3,144 |
| Fluticasone Propionate | 83 | $1,096 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 34 | $712 |
| Montelukast Sodium | 50 | $660 |
| Azelastine Hcl | 28 | $636 |
| Famotidine | 28 | $394 |
| Ipratropium Bromide | 11 | $384 |
| Hydrocortisone | 15 | $195 |
| Levocetirizine Dihydrochloride | 28 | $182 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $86 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| CSL BehringHizentra | $54 | $121,55612 claims |
| Bio Products Laboratory USA, Inc.Gammaplex | $41 | $86,93612 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 135 allergy & immunology providers in New Jersey.
Other allergy & immunology in Hackensack
- Ellen SherOcean$1M
- Peter RickettiTrenton$457K
- John KimMedford$339K
- Tina ZeccaLittle Silver$262K
- George BelecanechVoorhees$208K
- Jacqueline RossOcean$131K
- Shirin JadidiMendham$98K
- Mark WeinsteinBelleville$88K
- Joseph GrizzantiHawthorne$79K
- Lisa BariscianoFlorham Park$78K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.